In section Releases

Padagis Launches Naloxone Program to Meet New Workplace Safety Standards

With drug overdoses accounting for nearly one in ten workplace fatalities, pharmaceutical provider Padagis is distributing free naloxone nasal sprays to the first 200 qualifying businesses. The initiative aligns with the newly released ANSI/ISEA Z308.1-2026 standard, which identifies opioid reversal medication as a essential component of modern first aid kits.

Padagis Launches Naloxone Program to Meet New Workplace Safety Standards

The updated safety guidelines from the American National Standards Institute and the International Safety Equipment Association mark a pivot in industrial emergency preparedness. The standard recommends that employers maintain at least two doses of naloxone in clearly marked locations, alongside traditional first aid supplies. While the program targets high-risk sectors like construction, manufacturing, and hospitality, the broader goal is to integrate overdose response into routine safety protocols.

Padagis CEO Pamela Hoffman emphasized that the effectiveness of the medication relies on accessibility and staff training. The company, based in Allegan, Michigan, aims to remove financial barriers for organizations looking to comply with the new safety requirements. ISEA President Cam Mackey noted that treating naloxone as a standard emergency tool allows workplaces to respond with greater speed and certainty. Interested businesses can apply for the initial supply through the company's dedicated portal, naloxoneworkplace.com.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!